Molecular background of skin melanoma development and progression: therapeutic implications

Magdalena Olbryt

doi:10.5114/ada.2019.84590

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

2/2019
vol. 36

Send email

Copy url:

abstract:

Review paper

Molecular background of skin melanoma development and progression: therapeutic implications

Magdalena Olbryt

Adv Dermatol Allergol 2019; XXXVI (2): 129-138

DOI: https://doi.org/10.5114/ada.2019.84590

Online publish date: 2019/05/14

View full text Get citation

Melanoma is the most aggressive skin cancer with an increasing number of cases worldwide and curable mostly in its early stage. The improvement in patients’ survival in advanced melanoma has been achieved only recently, due to development of new biological drugs for targeted therapies and immunotherapy. Further progress in the treatment of melanoma is clearly dependent on the better understanding of its complex biology. This review describes the most important molecular mechanisms and genetic events underlying skin melanoma development and progression, depicts the way of action of newly developed drugs and indicates new potential therapeutic targets.

keywords:

Molecular background of skin melanoma development and progression: therapeutic implications

Magdalena Olbryt

melanoma, BRAF, targeted therapy, immunotherapy